RATIONALE, DESIGN AND BASELINE CHARACTERISTICS OF PEDIATRIC RENAL TRANSPLANT RECIPIENTS IN CRADLE STUDY: A RANDOMISED STUDY TO EVALUATE THE EFFECT OF EARLY EVEROLIMUS INITIATION TO REDUCE CALCINEURIN INHIBITOR EXPOSURE AND TO WITHDRAW STEROID

被引：0
|
作者：
Pape, Lars [1 ]
TOenshoff, Burkhard [2 ]
Ettenger, Robert [3 ]
Dello Strologo, Luca [4 ]
Martzloff, El-djouher [5 ]
Ng, Jennifer [6 ]
Lopez, Patricia [5 ]
机构：
[1] Hannover Med Sch, D-30623 Hannover, Germany
[2] Univ Klinikum Heidelberg, Heidelberg, Germany
[3] Ucla Ctr Hlth Sci, Los Angeles, CA USA
[4] Bambino Gesu Pediat Hosp, Rome, Italy
[5] Novartis Pharma Ag, Basel, Switzerland
[6] Novartis Pharmaceut, E Hanover, NJ USA
来源：
PEDIATRIC NEPHROLOGY | 2015年 / 30卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
P - 442
引用
收藏
页码：1712 / 1712
页数：1
相关论文
共 35 条
  • [1] BASELINE CHARACTERISTICS OF CRADLE STUDY EVALUATING THE EFFECT OF EARLY EVEROLIMUS INITIATION TO REDUCE CALCINEURIN INHIBITOR EXPOSURE AND TO WITHDRAW STEROID IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS
    Toenshoff, B.
    Ettenger, R.
    Pape, L.
    Dello, Strologo L.
    Martzloff, D.
    Vergara, M.
    Ng, J.
    Lopez, P.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 402 - 402
  • [2] Design And Baseline Characteristics Of Cradle: A Study Evaluating The Efficacy And Safety Of Everolimus To Reduce Cni Exposure And To Withdraw Steroids In Pediatric Renal Transplant Recipients
    Christian, Martin
    Bjerre, Anna
    Wennberg, Lars
    Ettenger, Robert
    Pape, Ears
    Tonshoff, Burlchard
    Dello Strologo, Luca
    Niaudet, Patrick
    Nlartzloff, El-djouher
    Vergara, Marcela
    Balfour, Alison
    Lopez, Patricia
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1755 - 1755
  • [3] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED TACROLIMUS IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS: DESIGN AND BASELINE CHARACTERISTICS OF CRADLE STUDY
    Martins, S.
    Pape, L.
    Toenshoff, B.
    Dello Strologo, L.
    Ettenger, R.
    Martzloff, D.
    Lopez, P.
    Vergara, M.
    Ng, J.
    PEDIATRIC TRANSPLANTATION, 2015, 19 : 70 - 70
  • [4] Rationale and design of a study evaluating the efficacy and safety of early conversion of calcineurin inhibitor to everolimus in paediatric renal transplant recipients
    Dello Strologo, Luca
    Toenshoff, Burkhard
    Pape, Lars
    Ettenger, Robert
    Niaudet, Patrick
    Martzloff, El-Djouher
    Vergara, Marcela
    Balfour, Alison
    Cornu-Artis, Catherine
    PEDIATRIC NEPHROLOGY, 2012, 27 (09) : 1816 - 1816
  • [5] Everolimus With Reduced Exposure to a Calcineurin Inhibitor in Pediatric Liver Transplant Recipients: Baseline Data From the H2305 Study.
    Ganschow, R.
    Fischer, L.
    Ericzon, B.
    Dhawan, A.
    D'Alessandro, A.
    Goss, J.
    Sips, C.
    Balfour, A.
    Junge, G.
    TRANSPLANTATION, 2014, 98 : 719 - 719
  • [6] Everolimus With Reduced Exposure to a Calcineurin Inhibitor in Pediatric Liver Transplant Recipients: Baseline Data From the H2305 Study.
    Ganschow, R.
    Fischer, L.
    Ericzon, B.
    Dhawan, A.
    D'Alessandro, A.
    Goss, J.
    Sips, C.
    Balfour, A.
    Junge, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 719 - 719
  • [7] TRANSFORM STUDY TO EVALUATE THE EFFECT OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITORS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: BASELINE DATA
    Arns, W.
    Weithofer, P.
    Witzke, O.
    Habicht, A.
    Banas, B.
    Renders, L.
    Rath, T.
    Lehner, F.
    Bartels, M.
    Von der Giet, M.
    Sommerer, C.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 25 - 25
  • [8] Effect of Everolimus with Reduced-Exposure Tacrolimus and Early Steroid Elimination in Pediatric Kidney Transplant Recipients: 36-Month Outcomes from the CRADLE Study.
    Silva, H. Tedesco
    Ettenger, R.
    Bjerre, A.
    Christian, M.
    Dello Strologo, L.
    Marks, S. D.
    Pape, L.
    Lopez, P.
    Cousin, M.
    Pandey, P.
    Rauer, B.
    Meier, M.
    Tonshoff, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 374 - 374
  • [9] Early Converison of Calcineurin Inhibitor to Everolimus in De Novo Renal Transplant Recipients and Its Impact on Cardiovascular Parameters: The ELEVATE Study Design
    van der Giet, M.
    de Fijter, J. W.
    Holdaas, H.
    Legendre, C.
    Neumayer, H. H.
    Machein, U.
    Junge, G.
    Cruzado, J. M.
    TRANSPLANTATION, 2012, 94 (10) : 991 - 991
  • [10] TRANSFORM: A NOVEL STUDY TO EVALUATE THE EFFECT OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITORS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: BASELINE DATA
    Pascual, Julio
    TRANSPLANT INTERNATIONAL, 2015, 28 : 442 - 442
1234